相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chronic Amyloid β Oligomer Infusion Evokes Sustained Inflammation and Microglial Changes in the Rat Hippocampus via NLRP3
Csaba Fekete et al.
NEUROSCIENCE (2019)
Microglia in Alzheimer's disease
David V. Hansen et al.
JOURNAL OF CELL BIOLOGY (2018)
Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future
Jeffrey Cummings et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Small Molecules: Therapeutic Application in Neuropsychiatric and Neurodegenerative Disorders
Stefania Schiavone et al.
MOLECULES (2018)
TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function
Yingjun Zhao et al.
NEURON (2018)
Amyloid beta deposition related retinal pigment epithelium cell impairment and subretinal microglia activation in aged APPswePS1 transgenic mice
Zhi-Zhang Dong et al.
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY (2018)
Microglia in Alzheimer's Disease: Activated, Dysfunctional or Degenerative
Victoria Navarro et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
Fuyuki Kametani et al.
FRONTIERS IN NEUROSCIENCE (2018)
The Quest for an Alzheimer Therapy
Stefano F. Cappa
FRONTIERS IN NEUROLOGY (2018)
Co-inhibition of immunoproteasome subunits LMP2 and LMP7 is required to block autoimmunity
Michael Basler et al.
EMBO REPORTS (2018)
Required Immunoproteasome Subunit Inhibition Profile for Anti-Inflammatory Efficacy and Clinical Candidate KZR-616 ((2S,3R)-N-((S)-3-(Cyclopent-1-en-1-yl)-((R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-hydroxy-3-(4-methoxyphenyl)-2-((S)-2-(2-morpholinoacetamido)propanamido)propenannide)
Henry W. B. Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Immunoproteasome Inhibition Impairs T and B Cell Activation by Restraining ERK Signaling and Proteostasis
Christian Schmidt et al.
FRONTIERS IN IMMUNOLOGY (2018)
Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015
Dev Mehta et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells
Li Ma et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Mouse Models of Alzheimer's Disease
Gisela Esquerda-Canals et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Immunoproteasome subunit deficiency has no influence on the canonical pathway of NF-κB activation
Annegret Bitzer et al.
MOLECULAR IMMUNOLOGY (2017)
Neurotoxic reactive astrocytes are induced by activated microglia
Shane A. Liddelow et al.
NATURE (2017)
The complexities underlying age-related macular degeneration: could amyloid beta play an important role
Savannah A. Lynn et al.
NEURAL REGENERATION RESEARCH (2017)
The Failure of Solanezumab - How the FDA Saved Taxpayers Billions
Chana A. Sacks et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Discovery of Highly Selective Inhibitors of the Immunoproteasome Low Molecular Mass Polypeptide 2 (LMP2) Subunit
Henry W. B. Johnson et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
The role of the immunoproteasome in interferon-γ-mediated microglial activation
Kasey E. Moritz et al.
SCIENTIFIC REPORTS (2017)
Immunoproteasome deficiency alters microglial cytokine response and improves cognitive deficits in Alzheimer's disease-like APPPS1 mice
Lisa K. Wagner et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
LOW NEUROTOXICITY OF ONX-0914 SUPPORTS THE IDEA OF SPECIFIC IMMUNOPROTEASOME INHIBITION AS A SIDE-EFFECT-LIMITING, THERAPEUTIC STRATEGY
Laura von Brzezinski et al.
EUROPEAN JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY (2017)
Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation
Francesca Regen et al.
CURRENT ALZHEIMER RESEARCH (2017)
The Cellular Phase of Alzheimer's Disease
Bart De Strooper et al.
CELL (2016)
High-Resolution Snapshots of Proteasome Inhibitors in Action Revise Inhibition Paradigms and Inspire Next-Generation Inhibitor Design
Kimberly Carmony et al.
CHEMBIOCHEM (2016)
Treatment for Rheumatoid Arthritis and Risk of Alzheimer's Disease: A Nested Case-Control Analysis
Richard C. Chou et al.
CNS DRUGS (2016)
Targeting tau protein in Alzheimer's disease
Michael S. Rafii
LANCET (2016)
Specificity of Protein Covalent Modification by the Electrophilic Proteasome Inhibitor Carfilzomib in Human Cells
Joel D. Federspiel et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design
Jil Schrader et al.
SCIENCE (2016)
Astrocytes: Key Regulators of Neuroinflammation
Emanuela Colombo et al.
TRENDS IN IMMUNOLOGY (2016)
MEDICINE AND THE MEDIA No breakthrough in Alzheimer's disease
Jacqui Wise
BMJ-BRITISH MEDICAL JOURNAL (2016)
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease
Francesco Panza et al.
BIOMED RESEARCH INTERNATIONAL (2016)
MEDICINE AND THE MEDIA No breakthrough in Alzheimer's disease
Jacqui Wise
BMJ-BRITISH MEDICAL JOURNAL (2016)
Amyloidosis in Retinal Neurodegenerative Diseases
Ambra Masuzzo et al.
FRONTIERS IN NEUROLOGY (2016)
MW151 Inhibited IL-1β Levels after Traumatic Brain Injury with No Effect on Microglia Physiological Responses
Adam D. Bachstetter et al.
PLOS ONE (2016)
The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation
Anja Henn
ALTEX-Alternatives to Animal Experimentation (2016)
Targeting neuroinflammation in Alzheimer's disease
Maria Rosanna Bronzuoli et al.
JOURNAL OF INFLAMMATION RESEARCH (2016)
The immunoproteasome β5i subunit is a key contributor to ictogenesis in a rat model of chronic epilepsy
Michele Mishto et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Dementia of the eye: the role of amyloid beta in retinal degeneration
J. A. Ratnayaka et al.
EYE (2015)
Systemic inflammation and microglial activation: systematic review of animal experiments
Inge C. M. Hoogland et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Tau Immunotherapy Modulates Both Pathological Tau and Upstream Amyloid Pathology in an Alzheimer's Disease Mouse Model
Diana L. Castillo-Carranza et al.
JOURNAL OF NEUROSCIENCE (2015)
Role of Traditional Nonsteroidal Anti-inflammatory Drugs in Alzheimer's Disease: A Meta-analysis of Randomized Clinical Trials
Prem Prakash Gupta et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2015)
Memory Impairment in Estrogen Receptor α Knockout Mice Through Accumulation of Amyloid-β Peptides
Chul Ju Hwang et al.
MOLECULAR NEUROBIOLOGY (2015)
Reducing Effect of IL-32 alpha in the Development of Stroke Through Blocking of NF-kappa B, but Enhancement of STAT3 Pathways
Chul Ju Hwang et al.
MOLECULAR NEUROBIOLOGY (2015)
Anti-Inflammatory Drugs and Risk of Alzheimer's Disease: An Updated Systematic Review and Meta-Analysis
Jun Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Regulation of proteasome activity in health and disease
Marion Schmidt et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
The Prevalence of Age-Related Macular Degeneration in Alzheimer's Disease
Michael A. Williams et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Structure-Based Design of β1i or β5i Specific Inhibitors of Human Immunoproteasomes
Gerjan de Bruin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Inhibitory effect of ent-Sauchinone on amyloidogenesis via inhibition of STAT3-mediated NF-κB activation in cultured astrocytes and microglial BV-2 cells
Suk-Young Song et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models
Scott J. Webster et al.
FRONTIERS IN GENETICS (2014)
Results of a follow-up study to the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT) The Alzheimer's Disease Anti-inflammatory Prevention Trial Research Group
John Breitner et al.
ALZHEIMERS & DEMENTIA (2013)
Reactive glia show increased immunoproteasome activity in Alzheimer's disease
Marie Orre et al.
BRAIN (2013)
The immunoproteasome in antigen processing and other immunological functions
Michael Basler et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Bimolecular Fluorescence Complementation; Lighting-Up Tau-Tau Interaction in Living Cells
HyeJin Tak et al.
PLOS ONE (2013)
Changes in Amyloid-β and Tau in the Cerebrospinal Fluid of Transgenic Mice Overexpressing Amyloid Precursor Protein
Luis F. Maia et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
The Aging Eye: Common Degenerative Mechanisms Between the Alzheimer's Brain and Retinal Disease
Jeremy M. Sivak
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Amyloid Generation and Dysfunctional Immunoproteasome Activation with Disease Progression in Animal Model of Familial Alzheimer's Disease
Ester Aso et al.
BRAIN PATHOLOGY (2012)
Mice completely lacking immunoproteasomes show major changes in antigen presentation
Eleanor Z. Kincaid et al.
NATURE IMMUNOLOGY (2012)
Alzheimer's Disease in the Retina: Imaging Retinal A beta Plaques for Early Diagnosis and Therapy Assessment
Yosef Koronyo et al.
NEURODEGENERATIVE DISEASES (2012)
PR-924, a selective inhibitor of the immunoproteasome subunit LMP-7, blocks multiple myeloma cell growth both in vitro and in vivo
Ajita V. Singh et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Age-Related Macular Degeneration (AMD): Alzheimer's Disease in the Eye?
Kai Kaarniranta et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1/2, iNOS and sPLA2-IIA expression in astrocytes and microglia
Wenwen Sheng et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration
Jin-Dong Ding et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Impairment of Immunoproteasome Function by β5i/LMP7 Subunit Deficiency Results in Severe Enterovirus Myocarditis
Elisa Opitz et al.
PLOS PATHOGENS (2011)
Immunoproteasomes Preserve Protein Homeostasis upon Interferon-Induced Oxidative Stress
Ulrike Seifert et al.
CELL (2010)
Viewing Ageing Eyes: Diverse Sites of Amyloid Beta Accumulation in the Ageing Mouse Retina and the Up-Regulation of Macrophages
Jaimie Hoh Kam et al.
PLOS ONE (2010)
Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome
Francesco Parlati et al.
BLOOD (2009)
Design and Synthesis of an Orally Bioavailable and Selective Peptide Epoxyketone Proteasome Inhibitor (PR-047)
Han-Jie Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis
Tony Muchamuel et al.
NATURE MEDICINE (2009)
β-Amyloid Deposition and Functional Impairment in the Retina of the APPswe/PS1ΔE9 Transgenic Mouse Model of Alzheimer's Disease
Sylvia E. Perez et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT)
ARCHIVES OF NEUROLOGY (2008)
Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation
Jae Woong Lee et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial
LANCET NEUROLOGY (2008)
Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myelorna
Deborah J. Kuhn et al.
BLOOD (2007)
A specific amyloid-β protein assembly in the brain impairs memory
S Lesné et al.
NATURE (2006)
Morris water maze: procedures for assessing spatial and related forms of learning and memory
Charles V. Vorhees et al.
NATURE PROTOCOLS (2006)
Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains
M Mishto et al.
NEUROBIOLOGY OF AGING (2006)
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease
BA in 't Veld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Immunoproteasome assembly and antigen presentation in mice lacking both PA28α and PA28β
S Murata et al.
EMBO JOURNAL (2001)
Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease
L Ho et al.
ARCHIVES OF NEUROLOGY (2001)
Lack of proteasome active site allostery as revealed by subunit-specific inhibitors
J Myung et al.
MOLECULAR CELL (2001)
分享论文
